Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years

Mauro Maccarrone; Vincenzo Di Marzo; Juerg Gertsch; Uwe Grether; Allyn C. Howlett; Tian Hua; Alexandros Makriyannis; Daniele Piomelli; Natsuo Ueda; Mario van der Stelt

doi:10.1124/pharmrev.122.000600

OtherReview Article

Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years

Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C. Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda and Mario van der Stelt

Pharmacological Reviews May 10, 2023, PHARMREV-AR-2022-000600; DOI: https://doi.org/10.1124/pharmrev.122.000600

Mauro Maccarrone

1Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mauro Maccarrone
For correspondence: mauro.maccarrone@univaq.it

Vincenzo Di Marzo

2University of Laval, Quebec, Canada, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Juerg Gertsch

3University of Bern, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Uwe Grether

4Roche Innovation Center, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Allyn C. Howlett

5Physiology and Pharmacology, Wake Forest University, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tian Hua

6ShanghaiTech University, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexandros Makriyannis

7Northeastern University, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniele Piomelli

8University of California Irvine, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Natsuo Ueda

9Kagawa University School of Medicine, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mario van der Stelt

10Leiden University, Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

In this issue

Pharmacological Reviews

Vol. 75, Issue 5

1 Sep 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years

Message Subject (Your Name) has forwarded a page to you from Pharmacological Reviews

Message Body (Your Name) thought you would be interested in this article in Pharmacological Reviews.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherReview Article

Endocannabinoid System as a Therapeutic Target

Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C. Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda and Mario van der Stelt

Pharmacological Reviews May 10, 2023, PHARMREV-AR-2022-000600; DOI: https://doi.org/10.1124/pharmrev.122.000600

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherReview Article

Endocannabinoid System as a Therapeutic Target

Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C. Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda and Mario van der Stelt

Pharmacological Reviews May 10, 2023, PHARMREV-AR-2022-000600; DOI: https://doi.org/10.1124/pharmrev.122.000600

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years

Plain text

Vertical Tabs

Jump to comment:

In this issue

Endocannabinoid System as a Therapeutic Target

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals